Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
109.60
-2.80 (-2.49%)
Apr 29, 2026, 4:08 PM HKT

Asymchem Laboratories (Tianjin) Company Description

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally.

It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business.

The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.

Asymchem Laboratories (Tianjin) Co., Ltd.
Country China
Founded 1998
Industry Biotechnology
Sector Healthcare
Employees 10,617

Contact Details

Address:
No. 71, Seventh Avenue
Tianjin, 300457
China
Website asymchem.com.cn

Stock Details

Ticker Symbol 6821
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100004Z06
SIC Code 2834

Key Executives

Name Position
Rui Yang Co-Chief Executive Officer and Executive Director
Dr. Hao Hong Ph.D. Founder, Chairman and Chief Executive Officer
Da Zhang Chief Financial Officer, Chief Operating Officer, Senior Vice President and Executive Director
Jiang Yingwei Executive Vice President of Human Resources and Administration
Dr. Liang Hong Executive Vice President and Executive Director
Chaoyong Chen Executive Vice President of Manufacturing and Tech Transfer
Dr. Yan Zhou Senior Vice President of Quality Management
Xiangke Xu Senior Vice President and Board Secretary of Public Affairs and Regulatory Affairs & Legal Affairs
Elut Hsu Senior Vice President of U.S. Headquarters Operations and Business Development
Dr. Pingzhong Huang Ph.D. Senior Vice President of Business Development and Project Management